Astellas Pharma secures US FDA approval for ASTAGRAF XL Pharmaceutical Business Review ... for the prophylaxis of kidney transplant rejection in adult recipients. The prescription medicine used with other medicines is indicated for kidney transplant patients with mycophenolate mofetil (MMF) and corticosteroids, with or without ... |
